Data as of Dec 17
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Cadus Corp. engages in development and application of novel yeast-based and other drug discovery technologies. The company is presently seeking to license the subsidiary's drug discovery technologies and use all or a portion of its existing cash and, where feasible and appropriate, seek additional debt or equity financing, to acquire or invest in one or more companies or income producing assets. Cadus was founded on January 23, 1992 and is headquartered in New York, NY.

Contact Information

Cadus Corp.
767 Fifth Avenue
New York New York 10153-0023
P:(212) 702-4300
Investor Relations:



Other institutional69.79%
Individual stakeholders25.97%
Mutual fund holders0.72%

Top Executives

Hunter Clark GaryPresident, Chief Executive Officer & Director
David BlitzChief Financial Officer, Secretary & Treasurer
James R. BroachDirector & Research Director

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.